Healthcare provider profile · identity verified

Laurel Ann Verant, D.O.

Internal Medicine · COLORADO SPRINGS, CO · NPI 1295173151

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	372	111
Levothyroxine Sodium	Levothyroxine Sodium	326	83
Rosuvastatin Calcium	Rosuvastatin Calcium	230	67
Losartan Potassium	Losartan Potassium	227	68
Lisinopril	Lisinopril	223	68
Omeprazole	Omeprazole	180	57
Amlodipine Besylate	Amlodipine Besylate	169	52
Alendronate Sodium	Alendronate Sodium	138	48
Gabapentin	Gabapentin	131	43
Albuterol Sulfate Hfa	Albuterol Sulfate	111	48
Arexvy	Rsvpref3 Antigen/As01e/Pf	107	107
Simvastatin	Simvastatin	104	29
Trazodone Hcl	Trazodone Hcl	100	31
Fluoxetine Hcl	Fluoxetine Hcl	78	19
Duloxetine Hcl	Duloxetine Hcl	77	22
Tramadol Hcl	Tramadol Hcl	69	15
Escitalopram Oxalate	Escitalopram Oxalate	67	21
Ezetimibe	Ezetimibe	65	22
Bupropion Xl	Bupropion Hcl	64	15
Pradaxa	Dabigatran Etexilate Mesylate	64	22
Pantoprazole Sodium	Pantoprazole Sodium	60	22
Metformin Hcl	Metformin Hcl	59	19
Metoprolol Tartrate	Metoprolol Tartrate	55	17
Furosemide	Furosemide	53	21
Hydrochlorothiazide	Hydrochlorothiazide	52	21
Oxycodone Hcl	Oxycodone Hcl	52	suppressed
Tamsulosin Hcl	Tamsulosin Hcl	52	21
Celecoxib	Celecoxib	49	19
Potassium Chloride	Potassium Chloride	46	17
Metformin Hcl Er	Metformin Hcl	45	15
Zolpidem Tartrate	Zolpidem Tartrate	44	11
Acyclovir	Acyclovir	42	15
Metoprolol Succinate	Metoprolol Succinate	42	17
Sertraline Hcl	Sertraline Hcl	42	14
Triamcinolone Acetonide	Triamcinolone Acetonide	41	21
Wixela Inhub	Fluticasone Propion/Salmeterol	40	16
Venlafaxine Hcl Er	Venlafaxine Hcl	39	12
Allopurinol	Allopurinol	38	11
Estradiol	Estradiol	38	17
Lorazepam	Lorazepam	37	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	35	suppressed
Glipizide	Glipizide	34	11
Alvesco	Ciclesonide	33	12
Amitriptyline Hcl	Amitriptyline Hcl	32	suppressed
Atenolol	Atenolol	32	suppressed
Adacel Tdap	Diph,pertuss(Acell),tet Vac/Pf	31	31
Meloxicam	Meloxicam	30	13
Montelukast Sodium	Montelukast Sodium	30	13
Naltrexone Hcl	Naltrexone Hcl	30	suppressed
Pregabalin	Pregabalin	30	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	30	suppressed
Warfarin Sodium	Warfarin Sodium	29	suppressed
Buspirone Hcl	Buspirone Hcl	28	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	27	suppressed
Carvedilol	Carvedilol	26	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	26	suppressed
Lovastatin	Lovastatin	23	suppressed
Mirtazapine	Mirtazapine	23	11
Pravastatin Sodium	Pravastatin Sodium	23	suppressed
Jardiance	Empagliflozin	22	suppressed
Citalopram Hbr	Citalopram Hydrobromide	20	suppressed
Spironolactone	Spironolactone	20	suppressed
Famotidine	Famotidine	19	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	19	suppressed
Donepezil Hcl	Donepezil Hcl	18	suppressed
Alprazolam	Alprazolam	17	suppressed
Cefuroxime	Cefuroxime Axetil	16	12
Hydroxyzine Hcl	Hydroxyzine Hcl	16	suppressed
Finasteride	Finasteride	15	suppressed
Clobetasol Propionate	Clobetasol Propionate	14	suppressed
Clopidogrel	Clopidogrel Bisulfate	14	suppressed
Spiriva Respimat	Tiotropium Bromide	14	suppressed
Topiramate	Topiramate	14	suppressed
Baclofen	Baclofen	13	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	13	13
Prednisone	Prednisone	13	12
Repatha Sureclick	Evolocumab	13	suppressed
Shingrix	Varicella-Zoster Ge/As01b/Pf	13	12
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	12	suppressed
Humulin N Kwikpen	Insulin Nph Human Isophane	12	suppressed
Ondansetron Odt	Ondansetron	12	suppressed
Ozempic	Semaglutide	12	suppressed
Trulance	Plecanatide	12	suppressed
Chlorthalidone	Chlorthalidone	11	suppressed
Fluticasone Propionate	Fluticasone Propionate	11	suppressed
Hydrocortisone	Hydrocortisone	11	suppressed
Propranolol Hcl	Propranolol Hcl	11	suppressed
Solifenacin Succinate	Solifenacin Succinate	11	suppressed
Valacyclovir	Valacyclovir Hcl	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error